Using the Braden Scale to Predict ICU Length of Stay
The Effect of the Braden Pressure Ulcer Scale on the Prediction of Intensive Care Unit Length of Stay
Ankara City Hospital Bilkent · NCT06697340
This study is trying to see if a tool that measures pressure ulcer risk can help predict how long patients will stay in the ICU.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ankara City Hospital Bilkent (other) |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06697340 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine if the Braden pressure ulcer risk assessment scale can predict the length of stay for patients in the intensive care unit (ICU). By recording Braden scale scores daily for patients admitted to a tertiary general ICU, the study seeks to analyze the relationship between high Braden scores and prolonged ICU stays. The Braden scale evaluates factors such as sensory perception, humidity, activity, mobility, nutrition, and friction/cutting, which are crucial for assessing patients' risk of pressure ulcers and overall functional capacity. The findings could help improve patient management and resource allocation in intensive care settings.
Who should consider this trial
Good fit: Ideal candidates for this study are patients over 18 years old who are being treated in the ICU for conditions other than Covid-19 and have been hospitalized for more than 24 hours.
Not a fit: Patients under 18 years old, those treated for Covid-19, or those with incomplete data in the hospital's electronic system may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the ability to predict ICU length of stay, potentially improving patient outcomes and resource management.
How similar studies have performed: Previous studies have shown the Braden scale to be effective in predicting outcomes such as mortality in various patient populations, indicating potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients older than 18 years * Patients treated in intensive care * Patients treated with diagnoses other than Covid-19 * Patients without missing data in the hospital electronic data system * Patients hospitalized for more than 24 hours Exclusion Criteria: * Patients younger than 18 years * Patients treated for Covid-19 disease * Patients with missing data in the hospital electronic data system * Patients hospitalized for less than 24 hours
Where this trial is running
Ankara
- Ankara Bilkent City Hospital — Ankara, Turkey (RECRUITING)
Study contacts
- Study coordinator: Cihangir Doğu
- Email: cihangirdogu@gmail.com
- Phone: +903125526000-601402
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Intensive Care Unit ICU, Length of ICU Stay, Pressure Ulcer Risk, Scale Reliability Validity, Braden risk assesment scale, Length of stay, ICU